Rolapitant Production Cost Reports

The report provides a detailed analysis essential for establishing a Rolapitant production plant. It encompasses all critical aspects necessary for Rolapitant production, including the cost of Rolapitant production, Rolapitant plant cost, Rolapitant production costs, and the overall Rolapitant production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Rolapitant production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Rolapitant is a medicine that helps prevent nausea and vomiting caused by chemotherapy. It works by blocking a chemical called substance P in the brain and gut, which triggers vomiting. It's a single pill taken about 1–2 hours before their chemotherapy, along with other medicines like granisetron and dexamethasone. The dose is repeated only once every chemotherapy cycle, which lasts two weeks. It helps to avoid vomiting and the need for extra medicine during the delayed phase after chemotherapy.

The drug stays active in the body for a long time, so one dose works for several days. It has fewer interactions with some liver enzymes compared to similar drugs, but it can affect other enzymes and transporters. Its common side effects include decreased appetite, hiccups, stomach pain or discomfort, dizziness, and neutropenia.

The market for Rolapitant is driven by rising cancer cases around the world. The expanding chemotherapy patient populations, along with FDA approval, contribute to its demand in delayed nausea prevention. Also, approvals from oncology guidelines like MASCC/ESMO and its single-dose convenience further fuel its demand in cisplatin-based therapies.

The industrial Rolapitant procurement is influenced by cost-effectiveness because of tenders, rate contracts, and Patient Access Schemes, reducing incremental costs. Other factors, like cheaper generic versions of similar drugscutting into sales, and strict rules needing proof that other anti-nausea meds failed first, affect its utilisation.

Raw Material for Rolapitant Production

According to the Rolapitant production plant project report, the key raw materials used in the production of Rolapitant include 27a-Sulfonate Intermediate-Zinc Powder-Acetic Acid-Toluene.

Production Process of Rolapitant

The extensive Rolapitant production cost report consists of the following major industrial production process:

1. From Nitro Piperidine Sulfonate Intermediate: The production process of Rolapitant involves the reduction of a nitro piperidine sulfonate intermediate (27a-sulfonate). 27a-sulfonate derivative is reduced with zinc in acetic acid, taking toluene as the solvent. This leads to salt formation and controlled recrystallisation to obtain rolapitant hydrochloride anhydrous. The crude product is further purified to get pure rolapitant hydrochloride as the final product.

Rolapitant appears as a white to off-white, slightly hygroscopic crystalline powder in its hydrochloride monohydrate form. It has a molecular formula of C25H26F6N2O2 with a molecular weight of 500.49 g/mol. It has three chiral centres with 2 hydrogen bond donors, 7 rotatable bonds. It has a topological polar surface area of 50.36 Ų and high lipophilicity with an XLogP value of 5.24. It shows pH-dependent solubility peaking at pH 2–4, no polymorphism in monohydrate form, and 99.8% plasma protein binding. It remains stable without epimerisation, and is primarily metabolised by CYP3A4 to the active hydroxy metabolite M19.